| Lonza | 79.97 |
| Date/Time | 10/21 / 00:00 |
| Chg. / Chg.(%) | - / |
| Bid | 79.97 / 100 |
| Ask | - |
| Open | 79.97 |
| Previous Close | - |
| High | 79.97 |
| Low | 79.97 |
| Volume [SGD] | - |
| Volume [Units] | 500 |
| Price fixings | |
| ISIN | CH0013841017 |
| Security | O6Z |
| Exchange | Singapore |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 541.600 |  |
|
| SIX Swiss Ex.. | 587.40 | |
279,020 |
| London Inter.. | 587.40 | |
33,699 |
| Nasdaq Other.. | 663.0400 | |
103 |
| Mexico | 13,159.94 |  |
270 |
| Cboe Europe .. | 328.30 | 47,868 | |
| Turquoise | 328.30 | |
18,782 |
| Cboe Europe .. | 328.00 | 12,923 | |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
12/16/2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
12/07/2020 / 22:05 - GlobeNewswire
Real-time